After adjustment for age, nodal status, tumor stage, grade, and continuous AR expression, the trend became significant for IDFS (HR 0.91 (95% C.I. 0.96–1.00); p = 0.049), but not for BCSS and DRFI. The gene discussed is AR; the disease is neoplasm.